Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Recent developments in age-related macular degeneration: a reviewClinical interventions in aging, 2017-01, Vol.12, p.1313-1330 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Al-Zamil and Yassin. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S143508 ;PMID: 28860733Full text available |
|
2 |
Material Type: Article
|
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular DegenerationArchives of ophthalmology (1960), 2021-04, Vol.139 (4), p.441 [Peer Reviewed Journal]Copyright American Medical Association Apr 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.7085Full text available |
|
3 |
Material Type: Article
|
Age-related macular degenerationThe Lancet (British edition), 2018-09, Vol.392 (10153), p.1147-1159 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31550-2 ;PMID: 30303083Full text available |
|
4 |
Material Type: Article
|
A systems biology approach towards understanding and treating non-neovascular age-related macular degenerationNature communications, 2019-07, Vol.10 (1), p.3347-11, Article 3347 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-11262-1 ;PMID: 31350409Full text available |
|
5 |
Material Type: Article
|
Mechanisms of age-related macular degeneration and therapeutic opportunitiesThe Journal of pathology, 2014-01, Vol.232 (2), p.151-164 [Peer Reviewed Journal]Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. ;ISSN: 0022-3417 ;EISSN: 1096-9896 ;DOI: 10.1002/path.4266 ;PMID: 24105633Full text available |
|
6 |
Material Type: Article
|
Predicting conversion to wet age-related macular degeneration using deep learningNature medicine, 2020-06, Vol.26 (6), p.892-899 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0867-7 ;PMID: 32424211Full text available |
|
7 |
Material Type: Article
|
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic optionsBritish Journal of Ophthalmology, 2017-01, Vol.101 (1), p.25-30 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2016-308823 ;PMID: 27491360 ;CODEN: BJOPALFull text available |
|
8 |
Material Type: Article
|
Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and TherapyInternational journal of molecular sciences, 2021-01, Vol.22 (3), p.1170 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22031170 ;PMID: 33504013Full text available |
|
9 |
Material Type: Article
|
Age-related macular degenerationThe Lancet (British edition), 2012-05, Vol.379 (9827), p.1728-1738 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60282-7 ;PMID: 22559899Full text available |
|
10 |
Material Type: Article
|
Age-Related Macular Degeneration Revisited – Piecing the Puzzle: The LXIX Edward Jackson Memorial LectureAmerican journal of ophthalmology, 2013, Vol.155 (1), p.1-35.e13 [Peer Reviewed Journal]Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2012.10.018 ;PMID: 23245386 ;CODEN: AJOPAAFull text available |
|
11 |
Material Type: Article
|
Incidence and multimodal imaging characteristics of macular neovascularisation subtypes in Chinese neovascular age-related macular degeneration patientsBritish journal of ophthalmology, 2023-01, Vol.108 (3), p.391-397 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjo-2022-322392 ;PMID: 36639223Full text available |
|
12 |
Material Type: Article
|
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular DegenerationAmerican journal of ophthalmology, 2023-08, Vol.252, p.170-181 [Peer Reviewed Journal]2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.03.033 ;PMID: 37030492Full text available |
|
13 |
Material Type: Article
|
The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retinaAging cell, 2020-02, Vol.19 (2), p.e13100-n/a [Peer Reviewed Journal]2020 The Authors. published by the Anatomical Society and John Wiley & Sons Ltd. ;2020 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1474-9718 ;EISSN: 1474-9726 ;DOI: 10.1111/acel.13100 ;PMID: 31943697Full text available |
|
14 |
Material Type: Article
|
The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular DegenerationInternational journal of molecular sciences, 2021-11, Vol.22 (21), p.12049 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms222112049 ;PMID: 34769482Full text available |
|
15 |
Material Type: Article
|
Review of Fibrosis in Neovascular Age-Related Macular DegenerationAmerican journal of ophthalmology, 2023-02, Vol.246, p.192-222 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.09.008 ;PMID: 36162537Full text available |
|
16 |
Material Type: Article
|
The eye as a complement dysregulation hotspotSeminars in immunopathology, 2018-01, Vol.40 (1), p.65-74 [Peer Reviewed Journal]The Author(s) 2017 ;Seminars in Immunopathology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 1863-2297 ;EISSN: 1863-2300 ;DOI: 10.1007/s00281-017-0649-6 ;PMID: 28948331Full text available |
|
17 |
Material Type: Article
|
Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degenerationGraefe's archive for clinical and experimental ophthalmology, 2023-05, Vol.261 (5), p.1413-1421 [Peer Reviewed Journal]The Author(s) 2022 ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-022-05885-2Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Associations and Outcomes of Patients with Submacular Hemorrhage Secondary to Age-related Macular Degeneration in the IVAN TrialAmerican journal of ophthalmology, 2022-04, Vol.236, p.89-98 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.033 ;PMID: 34626573Full text available |
|
19 |
Material Type: Article
|
Age-related macular degeneration-clinical review and genetics updateClinical genetics, 2013-08, Vol.84 (2), p.160-166 [Peer Reviewed Journal]Published 2013. This article is a U.S. Government work and is in the public domain in the USA. ;2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2013 ;ISSN: 0009-9163 ;EISSN: 1399-0004 ;DOI: 10.1111/cge.12206 ;PMID: 23713713Full text available |
|
20 |
Material Type: Article
|
Emerging therapies and their delivery for treating age‐related macular degenerationBritish journal of pharmacology, 2022-05, Vol.179 (9), p.1908-1937 [Peer Reviewed Journal]2021 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15459 ;PMID: 33769566Full text available |